CHICAGO, Feb. 2, 2021
CHICAGO, Feb. 2, 2021 /PRNewswire/ -- According to the new market research report "Blood Culture Tests Market by Method (Automated, Conventional), Product (Consumable, Media, Instruments), Technology (PCR, Microarray, Proteomic), Application (Bacteremia, Mycobacterial), End User (Hospital, Academic Research) - Global Forecast to 2025", published by MarketsandMarkets™, the Blood Culture Tests Market is projected to reach USD 6.1 billion by 2025 from USD 4.0 billion in 2020, at a CAGR of 8.9%.
Browse in-depth TOC on "Blood Culture Tests Market"
199 – Tables
29 – Figures
190 – Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=159606753
The major factors driving the growth of the blood culture tests are increasing number of sepsis cases and high cost of treatment, rising geriatric population, high incidence of bloodstream infections, growth in the demand for rapid diagnostic techniques, and the high prevalence of infectious diseases. On the other hand, factors such as the high cost of automated instruments and a lack of skilled laboratory technicians are limiting the growth of this market.
The consumables segment accounted for the largest share of the blood culture tests market, by product, in 2019.
On the basis of product, the Blood culture test methods market is segmented into consumables, instruments, and software and services. Consumable is the largest and fastest-growing segment, in 2019. This segment is also projected to register the highest CAGR from 2020 to 2025. The recurring requirement of consumables as compared to instruments is the key factor driving the growth of this segment.
Reference Laboratories segment to grow at the highest CAGR in the blood culture tests market during the forecast period
On the basis of end users, the Blood culture test methods market is segmented into hospital laboratories, reference laboratories, academic research laboratories, and other laboratories (includes pathology laboratories, bacteriological laboratories, physician office laboratories, and independent research laboratories). The reference laboratories segment is expected to grow at the highest CAGR during the forecast period. The high growth of this segment is attributed to the increasing outsourcing of blood culture tests by hospitals to reference laboratories.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=159606753
North America will continue to dominate the blood culture tests market during the forecast period
On the basis of region, the blood culture test market has been segmented into five major regions, namely, North America, Europe, the Asia Pacific, Latin America, Middle East and Africa. In 2019, North America accounted for the largest share of the blood culture tests market. The large share of North America can be attributed to the increasing geriatric population, rising prevalence infections, and the presence of prominent players in the region.
Major players operating in the blood culture tests market include Becton, Dickinson and Company (US), Thermo Fisher Scientific, Inc. (US), bioMérieux SA (France), Luminex Corporation (US), Danaher Corporation (US), Bruker Corporation (US), IRIDICA (US), Roche Diagnostics (Switzerland), T2 Biosystems, Inc. (US), Anaerobe Systems, Inc. (US), OpGen, Inc. (US), Meditech Technologies India Private Limited (India), Carl Zeiss AG (Germany), Nikon Corporation (Japan), BINDER GmbH (Germany), Biobase Biotech (Jinan) Co., Ltd. (China), Scenker Biological Technology Co., Ltd. (China), Bulldog Bio, Inc. (US), Axiom Laboratories (India), and HiMedia Laboratories Pvt. Ltd. (India).
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=159606753
Browse Adjacent Markets: Medical Devices Market Research Reports & Consulting
Browse Related Reports:
Clinical Microbiology Market by Application (Food, Pharma, Manufacturing, Chemical, Environment), Disease (Respiratory, Std, Uti), Product (Instrument, Analyzer, Reagent), End User (Hospital, Diagnostic Lab, Academia) - Global Forecast to 2025
Blood Screening Market by Technology (Nucleic Acid Amplification, (Real Time PCR), ELISA (Chemiluminescence immunoassay), Rapid Test, Western Blot), Product (Instrument, Reagent & Kits, Software) & End User (Blood Bank, Hospital) - Global Forecast to 2025
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/blood-culture-test-market.asp
Visit Our Web Site: https://www.marketsandmarkets.com
Content Source: https://www.marketsandmarkets.com/PressReleases/blood-culture-test.asp